HSHarpreet Sangha

Harpreet Sangha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Harpreet Sangha has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effectiveness of Dextrose Prolotherapy for Rotator Cuff Tendinopathy: A Systematic Review

    by Michael Catapano, Kailia Zhang, Nimish Mittal, Harpreet Sangha, Kentaro Onishi, Darren de Sa

    Objective To systematically review and evaluate the efficacy and complication profile of prolotherapy using hyperosmolar dextrose solution injection for rotator cuff tendinopathy. Literature Survey MEDLINE, EMBASE, CINAHL, and the Cochrane Central Register of Controlled Trials (from inception to July 1st, 2019). Methodology A comprehensive search was completed to identify randomized controlled trials addressing prolotherapy using hyperosmolar dextrose solution for rotator cuff tendinopathy. Two reviewers independently screened the titles, abstracts, and full texts, and then extracted data from eligible studies. All reported outcome measures and complications were analyzed descriptively. Synthesis Five studies satisfied inclusion criteria. Included studies analyzed a total of 272 participants with a final follow‐up ranging 6‐weeks to 12‐months. Prolotherapy differed greatly among studies. Two studies used a multi‐site enthesis injection protocol while the other three used ultrasound‐guided protocols. Two of the studies used an intra‐substance supraspinatus injection and three a supraspinatus enthesis injection. Control groups consisted of non‐operative rehabilitation including physical therapy and medical management in three studies, supraspinatus saline enthesis injection in one study, and corticosteroid injection in one study. There was statistically significant improvement in pain intensity with multi‐site injection protocols compared to physical therapy and medical management in both studies. Ultrasound‐guided supraspinatus injection trials did not find any statistically significant difference in pain intensity, range of motion, strength, function or ultrasound characteristics compared to controls of enthesis saline injection or corticosteroid. The complication rate was low with only 6/272 participants experiencing adverse events consisting of transient increase in pain for 1‐2 days post‐intervention. Conclusion Prolotherapy with hyperosmolar dextrose solution is a potentially effective adjuvant intervention to physical therapy for patients with rotator cuff tendinopathy ranging from tendinosis to partial thickness and small full‐thickness tears. Further studies are necessary to determine effects in sub‐populations as well as optimal technique including dextrose concentration, volume, and location.


  • A Retrospective Study of the Association between Pain Intensity and Opioid Use with Length of Stay during Musculoskeletal Inpatient Rehabilitation after Primary Knee and Hip Arthroplasty

    by Bhupinder Sahota, Seyed Mohammad Alavinia, Dinesh Kumbhare, Harpreet Sangha, John Flannery, Andrea Furlan

    Background: The relationship between pain intensity, opioid consumption, and length of stay (LOS) has received little attention in primary, lower extremity joint arthroplasty patients admitted to inpatient musculoskeletal rehabilitation.Objective: To assess how initial pain and other clinical factors are associated with rehabilitation LOS.Design: Retrospective chart review.Setting: Rehabilitation hospital.Participants: One hundred ninety nine patients admitted for inpatient rehabilitation.Interventions: Not Applicable.Main Outcome Measures: Pain intensities on the Numeric Rating Scale (NRS) were completed 3 times daily and total daily opioid consumption recorded in terms of morphine equivalents (MEQ). Confounding variables included patient demographics, medical comorbidity burden using the Charlson Comorbidity Index (CCI), and early functional status as measured by the motor subscale from the Functional Independence Measure (FIM).Results: Mean day 3 NRS values of ≥5.2 and total day 3 opioid consumption of >50 MEQ were associated with a prolonged LOS by nearly 3 and 2 days, respectively. Within a multivariate linear regression, age, mean day 3 pain, comorbidity burden, and early motor functional status accounted for 36% of the variability seen in joint replacement rehabilitation LOS. With all other variables remaining constant, for every unit increase in mean day 3 pain and CCI, this amounted to an additional 5% and 4% increase to LOS, whereas each unit increase in admission motor FIM decreased estimated LOS by 3%.Conclusion: Mean pain intensity and total opioid consumption on day 3 of inpatient rehabilitation is associated with LOS. For the rehabilitation physician, this is useful information as the earlier identification of patients with poorly controlled pain can lead to directed intervention, better patient care, and significant cost savings.